A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice - Concepedia

Concepedia

Publication | Closed Access

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

56

Citations

65

References

2003

Year

Nicoletta Eliopoulos, A. Alkhaldi, Milena Crosato, Kevin Lachapelle, Jacques Galipeau

Regenerative MedicineVivo Systemic DeliveryCell TherapyBone Marrow FailureNeovascularized OrganoidMedicineBone Marrow StromaBiomedical EngineeringCell EngineeringCell Biology

References

	Year	Citations

Page 1